Roundtable Discussion: Assessing the Growing Importance of ADC Sequencing & Combination Approaches to Optimize Differentiated Clinical Performance
- Exploring the impact of ADC combinations on the oncology treatment landscape: Will combination therapies become the norm as more ADCs progress to earlier-line patient therapies?
- Debating the need for novel and out-the-box combination partners to enhance the clinical impact of ADC combination therapies
- Breaking down strategy and potential of ADC sequencing to best position ADCs for maximized clinical impact in patient sub-populations